PMID- 23876350 OWN - NLM STAT- MEDLINE DCOM- 20140428 LR - 20130909 IS - 2210-741X (Electronic) IS - 2210-7401 (Linking) VI - 37 IP - 4 DP - 2013 Sep TI - Benign hepatocellular nodules: what have we learned using the patho-molecular classification. PG - 322-7 LID - S2210-7401(13)00129-0 [pii] LID - 10.1016/j.clinre.2013.04.008 [doi] AB - Focal nodular hyperplasia (FNH) and hepatocellular adenoma (HCA) are benign hepatocellular tumors that develop most frequently in females and in non-cirrhotic livers. HCA are prone to bleed and to transform into hepatocellular carcinoma (HCC). Four major subgroups of HCA have been thus far identified: HNF1alpha mutated HCA, inflammatory HCA (IHCA), beta-catenin mutated HCA (b-HCA and b-IHCA), based on mutations in specific oncogenes and tumor suppressors. B-HCA and b-IHCA are strongly associated with HCC transformation. Benign hepatocellular tumors can be classified using immunohistochemistry (LFABP, CRP, GS, b-catenin). Analysis of HCA phenotypes has led to the identification of patients at risk of HCC transformation and therefore improved the indications provided by invasive and non-invasive diagnostic techniques, such as biopsies and MRI. These recent advances have broadened the clinical scope of HCA in various conditions, such as their presence in males, in obese patients, in patients suffering from liver vascular disorders, genetic diseases. However, specific immunohistochemistry has shown limitations particularly for the identification of b-HCA, thereby, outlining the importance of molecular studies to improve the diagnosis/prognosis of HCA. If evaluation of prognosis and treatment has benefited from these advances, much more needs to be done to obtain guidelines for good clinical practice. CI - Copyright (c) 2013 Elsevier Masson SAS. All rights reserved. FAU - Sempoux, Christine AU - Sempoux C AD - Service d'Anatomie Pathologique, Cliniques universitaires Saint-Luc, Universite catholique de Louvain, 1200 Brussels, Belgium. christine.sempoux@uclouvain.be FAU - Chang, Charissa AU - Chang C FAU - Gouw, Annette AU - Gouw A FAU - Chiche, Laurence AU - Chiche L FAU - Zucman-Rossi, Jessica AU - Zucman-Rossi J FAU - Balabaud, Charles AU - Balabaud C FAU - Bioulac-Sage, Paulette AU - Bioulac-Sage P LA - eng PT - Journal Article PT - Review DEP - 20130719 PL - France TA - Clin Res Hepatol Gastroenterol JT - Clinics and research in hepatology and gastroenterology JID - 101553659 SB - IM MH - Adenoma, Liver Cell/*classification/*pathology MH - Humans EDAT- 2013/07/24 06:00 MHDA- 2014/04/29 06:00 CRDT- 2013/07/24 06:00 PHST- 2013/02/19 00:00 [received] PHST- 2013/04/04 00:00 [revised] PHST- 2013/04/05 00:00 [accepted] PHST- 2013/07/24 06:00 [entrez] PHST- 2013/07/24 06:00 [pubmed] PHST- 2014/04/29 06:00 [medline] AID - S2210-7401(13)00129-0 [pii] AID - 10.1016/j.clinre.2013.04.008 [doi] PST - ppublish SO - Clin Res Hepatol Gastroenterol. 2013 Sep;37(4):322-7. doi: 10.1016/j.clinre.2013.04.008. Epub 2013 Jul 19.